Find

Department of Clinical Medicine

Medical/Steno Aarhus Research Laboratory

Publications

Search for a publication

List of publications

Sort by: Date | Author | Title

Sølling, A. S., Harsløf, T. & Langdahl, B. (2019). Treatment with zoledronic acid subsequent to odanacatib prevents bone loss in postmenopausal women with osteoporosis. Osteoporosis International, 30(5), 995-1002. https://doi.org/10.1007/s00198-018-04833-3

Sølling, A. S., Harsløf, T. & Langdahl, B. (2020). Treatment with zoledronate subsequent to denosumab in osteoporosis: a randomized trial. Journal of Bone and Mineral Research (JBMR), 35(10), 1858-1870. https://doi.org/10.1002/jbmr.4098

Sølling, A. S., Harsløf, T. & Langdahl, B. L. (2021). Treatment With Zoledronate Subsequent to Denosumab in Osteoporosis: A 2-Year Randomized Study. Journal of Bone and Mineral Research (JBMR), 36(7), 1245-1254. https://doi.org/10.1002/jbmr.4305

Teresa Muñoz-Calvo, M., Barrios, V., Pozo, J., Chowen, J. A., Martos-Moreno, G. Á., Hawkins, F., Dauber, A., Domené, H. M., Yakar, S., Rosenfeld, R. G., Pérez-Jurado, L. A., Oxvig, C., Frystyk, J. & Argente, J. (2016). Treatment with recombinant human insulin-like growth factor-1 improves growth in patients with PAPP-A2 deficiency. The Journal of Clinical Endocrinology & Metabolism, 101(11), 3879-3883. https://doi.org/10.1210/jc.2016-2751

Engebretsen, I., Malene Ødegaard, K., Halvorsen, S., Bugge, C., Kristiansen, I. S., Støvring, H. & Munkhaugen, J. (2025). Treatment with PCSK9 monoclonal antibodies is associated with discontinuation of oral lipid lowering therapy. European Heart Journal - Quality of Care & Clinical Outcomes, 11(8), 1290-1300. https://doi.org/10.1093/ehjqcco/qcae099

Hald, J. D., Hald, A. M. W., Harsløf, T., Langdahl, B. & Bruun, J. M. (2024). Treatment with bariatric surgery in patients with osteogenesis imperfecta and severe obesity. Bone Reports, 23, Article 101811. https://doi.org/10.1016/j.bonr.2024.101811

Buhl, E. S., Jensen, T. K., Jessen, N., Elfving, B., Buhl, C. S., Kristiansen, S. B., Pold, R., Solskov, L., Schmitz, O., Wegener, G., Lund, S. & Petersen, K. F. (2010). TREATMENT WITH AN SSRI ANTIDEPRESSANT RESTORES HIPPOCAMPO-HYPOTHALAMIC CORTICOSTEROID FEEDBACK AND REVERSES INSULIN RESISTANCE IN LOW BIRTH WEIGHT RATS. American Journal of Physiology: Endocrinology and Metabolism, 298(5), E920-9. https://doi.org/10.1152/ajpendo.00606.2009

Cosman, F., Langdahl, B. & Leder, B. Z. (2024). Treatment Sequence for Osteoporosis. Endocrine Practice, 30(5), 490-496. https://doi.org/10.1016/j.eprac.2024.01.014

Langdahl, B. L., Lorentzon, M., Borgen, T. T., Bajtner, E., Kaarill, T., Alstad, C., Rieem Dun, A., Konradsen, M. S., Liseth Hansen, J., Ström, O., Tsitlakidis, E. & Moayyeri, A. (2026). Treatment patterns of romosozumab in postmenopausal women with severe osteoporosis in Denmark: findings from the ROmosozumab in Scandinavia real-world Evidence Study (ROSES). Osteoporosis International, 37(1), 167-178. https://doi.org/10.1007/s00198-025-07756-y

Engebretsen, I., Bugge, C., Støvring, H., Husebye, E., Sverre, E., Dammen, T., Halvorsen, S. & Munkhaugen, J. (2024). Treatment patterns and adherence to lipid-lowering drugs during eight-year follow-up after a coronary heart disease event. Atherosclerosis, 393, Article 117550. https://doi.org/10.1016/j.atherosclerosis.2024.117550

Displaying results 161 to 170 out of 4020

17

Revised 11.09.2025

-

Department of Clinical Medicine